XML 52 R41.htm IDEA: XBRL DOCUMENT v3.25.1

Segment Information (Tables)

3 Months Ended

Mar. 31, 2025

Segment Information [Abstract]

Schedule of Segment Information

		During the Three-Month Period Ended March 31, 2025
		Scours				Mastitis				Other				Total
Product sales		$	8,028,486			$	38,688			$	—			$	8,067,174
Costs of goods sold			4,674,543				38,659				—				4,713,202
Gross margin			3,353,943				29				—				3,353,972
Product development expenses			93,485				628,912				34,450				756,847
Sales and marketing expenses			787,137				69,521				—				856,658
Administrative expenses			—				—				622,843				622,843
Operating expenses			880,622				698,433				657,293				2,236,348
NET OPERATING INCOME (LOSS)		$	2,473,321			$	(698,404	)		$	(657,293	)		$	1,117,624

		During the Three-Month Period Ended March 31, 2024
		Scours				Mastitis				Other				Total
Product sales		$	7,220,641			$	36,936			$	—			$	7,257,577
Costs of goods sold			4,923,548				38,670				—				4,962,218
Gross margin			2,297,093				(1,734	)			—				2,295,359
Product development expenses			29,495				1,202,941				30,114				1,262,550
Sales and marketing expenses			669,739				131,184				—				800,923
Administrative expenses			—				—				531,938				531,938
Operating expenses			699,234				1,334,125				562,052				2,595,411
NET OPERATING INCOME (LOSS)		$	1,597,859			$	(1,335,859	)		$	(562,052	)		$	(300,052	)

		Scours				Mastitis				Other				Total
Total Assets as of March 31, 2025		$	24,486,105			$	16,340,874			$	4,794,600			$	45,621,579
Total Assets as of March 31, 2024		$	24,160,698			$	17,550,907			$	1,339,443			$	43,051,048
Depreciation and amortization expense during the three-month period ended March 31, 2025		$	352,522			$	314,659			$	19,592			$	686,773
Depreciation and amortization expense during the three-month period ended March 31, 2024		$	338,919			$	318,718			$	19,863			$	677,500
Capital Expenditures during the three-month period ended March 31, 2025		$	322,377			$	6,673			$	—			$	329,050
Capital Expenditures during the three month period ended March 31, 2024		$	54,976			$	15,380			$	—			$	70,356

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration